 | | AF9 | | Name: | 5-[2,4-bis(azanyl)pyrimidin-5-yl]oxy-2-methoxy-4-propan-2-yl-benzenesulfonamide | | Formula: | C14 H19 N5 O4 S | | SMILES: | COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1[S](N)(=O)=O | | InChi: | InChI=1S/C14H19N5O4S/c1-7(2)8-4-10(22-3)12(24(17,20)21)5-9(8)23-11-6-18-14(16)19-13(11)15/h4-7H,1-3H3,(H2,17,20,21)(H4,15,16,18,19) | | Synonyms: | AF-219 | | Definition date: | 2017-12-05 | | Last modified: | 2021-03-01 | | Release date: | 2018-04-04 | | Identifier: | 5-[2,4-bis(azanyl)pyrimidin-5-yl]oxy-2-methoxy-4-propan-2-yl-benzenesulfonamide |
|
 | | AFB | | Name: | 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE | | Formula: | C16 H24 O4 | | SMILES: | O=C1OC(CCCC=CC2C(C(O)C=C1)CC(O)C2)C | | InChi: | InChI=1S/C16H24O4/c1-11-5-3-2-4-6-12-9-13(17)10-14(12)15(18)7-8-16(19)20-11/h4,6-8,11-15,17-18H,2-3,5,9-10H2,1H3/b6-4+,8-7+/t11-,12+,13-,14+,15+/m0/s1 | | Synonyms: | BREFELDIN A | | Definition date: | 2003-11-12 | | Last modified: | 2021-03-01 | | Identifier: | (1R,2E,6S,10E,11aS,13S,14aR)-1,13-dihydroxy-6-methyl-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-4-one |
|
 | | H8G | | Name: | N,N-diethyl-N'-[(8alpha)-6-methyl-9,10-didehydroergolin-8-yl]urea | | Formula: | C20 H26 N4 O | | SMILES: | CCN(CC)C(=O)NC3C=C2c4cccc1c4c(cn1)CC2N(C)C3 | | InChi: | InChI=1S/C20H26N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,10-11,14,18,21H,4-5,9,12H2,1-3H3,(H,22,25)/t14-,18+/m0/s1 | | Synonyms: | lisuride | | Definition date: | 2018-06-15 | | Last modified: | 2021-03-01 | | Release date: | 2018-08-29 | | Identifier: | N,N-diethyl-N'-[(8alpha)-6-methyl-9,10-didehydroergolin-8-yl]urea |
|
 | | H8H | | Name: | N-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-7-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]-5-(TETRAHYDRO-2H-PYRAN-4-YLOXY)QUINAZOLIN-4-AMINE | | Formula: | C27 H32 Cl N5 O5 | | SMILES: | Clc2ccc1OCOc1c2Nc6ncnc5c6c(OC3CCOCC3)cc(OCCN4CCN(C)CC4)c5 | | InChi: | InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31) | | Synonyms: | SARACATINIB | | Definition date: | 2006-06-14 | | Last modified: | 2021-03-01 | | Identifier: | N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine |
|
 | | H8J | | Name: | (8alpha)-N-[(2S)-1-hydroxybutan-2-yl]-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide | | Formula: | C21 H27 N3 O2 | | SMILES: | CCC(CO)NC(=O)C3C=C2c4cccc1c4c(cn1C)CC2N(C)C3 | | InChi: | InChI=1S/C21H27N3O2/c1-4-15(12-25)22-21(26)14-8-17-16-6-5-7-18-20(16)13(10-23(18)2)9-19(17)24(3)11-14/h5-8,10,14-15,19,25H,4,9,11-12H2,1-3H3,(H,22,26)/t14-,15+,19-/m1/s1 | | Synonyms: | methysergide | | Definition date: | 2018-06-15 | | Last modified: | 2021-03-01 | | Release date: | 2018-08-29 | | Identifier: | (8alpha)-N-[(2S)-1-hydroxybutan-2-yl]-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide |
|
 | | H8M | | Name: | (1S)-1-[(2-chloro-3,4-dimethoxyphenyl)methyl]-6-methyl-2,3,4,9-tetrahydro-1H-beta-carboline | | Formula: | C21 H23 Cl N2 O2 | | SMILES: | COc4ccc(CC1c2c(CCN1)c3cc(C)ccc3n2)c(c4OC)Cl | | InChi: | InChI=1S/C21H23ClN2O2/c1-12-4-6-16-15(10-12)14-8-9-23-17(20(14)24-16)11-13-5-7-18(25-2)21(26-3)19(13)22/h4-7,10,17,23-24H,8-9,11H2,1-3H3/t17-/m0/s1 | | Synonyms: | LY266097 | | Definition date: | 2018-06-15 | | Last modified: | 2021-03-01 | | Release date: | 2018-08-29 | | Identifier: | (1S)-1-[(2-chloro-3,4-dimethoxyphenyl)methyl]-6-methyl-2,3,4,9-tetrahydro-1H-beta-carboline |
|
 | | HBN | | Name: | N-(2-NAPHTHYL)HISTIDINAMIDE | | Formula: | C16 H16 N4 O | | SMILES: | O=C(Nc2cc1ccccc1cc2)C(N)Cc3cncn3 | | InChi: | InChI=1S/C16H16N4O/c17-15(8-14-9-18-10-19-14)16(21)20-13-6-5-11-3-1-2-4-12(11)7-13/h1-7,9-10,15H,8,17H2,(H,18,19)(H,20,21)/t15-/m1/s1 | | Synonyms: | L-HISTIDINE BETA NAPHTHYLAMIDE | | Definition date: | 2004-04-05 | | Last modified: | 2021-03-01 | | Identifier: | N-naphthalen-2-yl-D-histidinamide |
|
 | | HBV | | Name: | 3-fluoro-N-hydroxy-4-[(methyl{[(3s,5s,7s)-tricyclo[3.3.1.1~3,7~]decan-1-yl]methyl}amino)methyl]benzamide | | Formula: | C20 H27 F N2 O2 | | SMILES: | C(C13CC2CC(C1)CC(C2)C3)N(C)Cc4c(F)cc(C(=O)NO)cc4 | | InChi: | InChI=1S/C20H27FN2O2/c1-23(11-17-3-2-16(7-18(17)21)19(24)22-25)12-20-8-13-4-14(9-20)6-15(5-13)10-20/h2-3,7,13-15,25H,4-6,8-12H2,1H3,(H,22,24)/t13-,14+,15-,20- | | Synonyms: | Bavarostat | | Definition date: | 2018-06-25 | | Last modified: | 2021-03-01 | | Release date: | 2018-08-29 | | Identifier: | 3-fluoro-N-hydroxy-4-[(methyl{[(3s,5s,7s)-tricyclo[3.3.1.1~3,7~]decan-1-yl]methyl}amino)methyl]benzamide |
|
 | | HBY | | Name: | (S)-4-ISOPROPOXYCARBONYL-6-METHOXY-3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN-2(1H)-THIONE | | Formula: | C15 H20 N2 O3 S2 | | SMILES: | S=C2Nc1c(cc(OC)cc1)N(C(=O)OC(C)C)C2CSC | | InChi: | InChI=1S/C15H20N2O3S2/c1-9(2)20-15(18)17-12-7-10(19-3)5-6-11(12)16-14(21)13(17)8-22-4/h5-7,9,13H,8H2,1-4H3,(H,16,21)/t13-/m0/s1 | | Synonyms: | HBY 097 | | Definition date: | 1999-07-08 | | Last modified: | 2021-03-01 | | Identifier: | 1-methylethyl (2S)-7-methoxy-2-[(methylsulfanyl)methyl]-3-thioxo-3,4-dihydroquinoxaline-1(2H)-carboxylate |
|
 | | HC5 | | Name: | (R)-3-CARBOXY-2-(HEXANOYLOXY)-N,N,N-TRIMETHYLPROPAN-1-AMINIUM | | Formula: | C13 H26 N O4 | | SMILES: | O=C(O)CC(OC(=O)CCCCC)C[N+](C)(C)C | | InChi: | InChI=1S/C13H25NO4/c1-5-6-7-8-13(17)18-11(9-12(15)16)10-14(2,3)4/h11H,5-10H2,1-4H3/p+1/t11-/m1/s1 | | Synonyms: | HEXANOYLCARNITINE | | Definition date: | 2006-05-26 | | Last modified: | 2021-03-01 | | Identifier: | (2R)-3-carboxy-2-(hexanoyloxy)-N,N,N-trimethylpropan-1-aminium |
|
 | | HCD | | Name: | (3alpha,8alpha)-cholest-5-ene-3,20-diol | | Formula: | C27 H46 O2 | | SMILES: | OC(C4C3(C(C1C(C2(C(=CC1)CC(O)CC2)C)CC3)CC4)C)(C)CCCC(C)C | | InChi: | InChI=1S/C27H46O2/c1-18(2)7-6-14-27(5,29)24-11-10-22-21-9-8-19-17-20(28)12-15-25(19,3)23(21)13-16-26(22,24)4/h8,18,20-24,28-29H,6-7,9-17H2,1-5H3/t20-,21-,22-,23-,24-,25-,26-,27-/m0/s1 | | Synonyms: | 20S-hydroxycholesterol | | Definition date: | 2010-06-02 | | Last modified: | 2021-03-01 | | Identifier: | (3alpha,8alpha)-cholest-5-ene-3,20-diol |
|
 | | HCE | | Name: | {(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-hydroxypyrrolidin-3-yl}-L-methionine | | Formula: | C16 H24 N6 O3 S | | SMILES: | O=C(O)C(N)CCSCC3CN(Cc2cnc1c2ncnc1N)CC3O | | InChi: | InChI=1S/C16H24N6O3S/c17-11(16(24)25)1-2-26-7-10-5-22(6-12(10)23)4-9-3-19-14-13(9)20-8-21-15(14)18/h3,8,10-12,19,23H,1-2,4-7,17H2,(H,24,25)(H2,18,20,21)/t10-,11+,12+/m1/s1 | | Synonyms: | homocysteine-DADMe-Immucillin-A | | Definition date: | 2012-05-11 | | Last modified: | 2021-03-01 | | Release date: | 2013-05-01 | | Identifier: | {(3S,4R)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-hydroxypyrrolidin-3-yl}-L-methionine |
|
 | | HCM | | Name: | (2S)-2-amino-4-(methyldisulfanyl)butanoic acid | | Formula: | C5 H11 N O2 S2 | | SMILES: | O=C(O)C(N)CCSSC | | InChi: | InChI=1S/C5H11NO2S2/c1-9-10-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1 | | Synonyms: | S-methylsulfanyl-homocystein | | Definition date: | 2012-12-18 | | Last modified: | 2021-03-01 | | Release date: | 2013-12-18 | | Identifier: | (2S)-2-amino-4-(methyldisulfanyl)butanoic acid |
|
 | | HCY | | Name: | (11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione | | Formula: | C21 H30 O5 | | SMILES: | O=C(CO)C3(O)C2(CC(O)C4C1(C(=CC(=O)CC1)CCC4C2CC3)C)C | | InChi: | InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 | | Synonyms: | CORTISOL | | Definition date: | 2007-10-13 | | Last modified: | 2021-03-01 | | Identifier: | (11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione |
|
 | | HDC | | Name: | 3R-HYDROXYDECANOYL-COENZYME A | | Formula: | C31 H54 N7 O18 P3 S | | SMILES: | O=C(SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3OP(=O)(O)O)CC(O)CCCCCCC | | InChi: | InChI=1S/C31H54N7O18P3S/c1-4-5-6-7-8-9-19(39)14-22(41)60-13-12-33-21(40)10-11-34-29(44)26(43)31(2,3)16-53-59(50,51)56-58(48,49)52-15-20-25(55-57(45,46)47)24(42)30(54-20)38-18-37-23-27(32)35-17-36-28(23)38/h17-20,24-26,30,39,42-43H,4-16H2,1-3H3,(H,33,40)(H,34,44)(H,48,49)(H,50,51)(H2,32,35,36)(H2,45,46,47)/t19-,20-,24-,25-,26+,30-/m1/s1 | | Synonyms: | 3R-HYDROXYDECANOYL-COA | | Definition date: | 2003-06-17 | | Last modified: | 2021-03-01 | | Identifier: | S-{(9R,13S,15R)-17-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-9,13,15-trihydroxy-10,10-dimethyl-13,15-dioxido-4,8-dioxo-12,14,16-trioxa-3,7-diaza-13,15-diphosphaheptadec-1-yl} (3R)-3-hydroxydecanethioate (non-preferred name) |
|
 | | HDH | | Name: | 4-oxidanylbenzohydrazide | | Formula: | C7 H8 N2 O2 | | SMILES: | NNC(=O)c1ccc(O)cc1 | | InChi: | InChI=1S/C7H8N2O2/c8-9-7(11)5-1-3-6(10)4-2-5/h1-4,10H,8H2,(H,9,11) | | Synonyms: | 4-hydroxybenzoic acid hydrazide | | Definition date: | 2016-11-18 | | Last modified: | 2021-03-01 | | Release date: | 2017-02-01 | | Identifier: | 4-oxidanylbenzohydrazide |
|
 | | HDL | | Name: | D-arabinohydroxamic acid | | Formula: | C5 H9 N O7 | | SMILES: | O=C(NO)C(O)C(O)C(O)C(=O)O | | InChi: | InChI=1S/C5H9NO7/c7-1(3(9)5(11)12)2(8)4(10)6-13/h1-3,7-9,13H,(H,6,10)(H,11,12)/t1-,2+,3+/m1/s1 | | Synonyms: | D-arabinohydroxamate | | Definition date: | 2009-05-26 | | Last modified: | 2021-03-01 | | Identifier: | 1-(hydroxyamino)-D-lyxuronic acid |
|
 | | HEJ | | Name: | 9-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}-9H-purin-6-amine | | Formula: | C10 H16 N5 O13 P3 | | SMILES: | Nc1ncnc2c1ncn2C3OC(COP(O)(=O)OP(O)(=O)OP(O)(=O)O)C(O)C3O | | InChi: | InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7+,10-/m1/s1 | | Synonyms: | Vidarabine-TRIPHOSPHATE | | Definition date: | 2018-06-27 | | Last modified: | 2021-03-01 | | Release date: | 2018-10-24 | | Identifier: | 9-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}-9H-purin-6-amine |
|
 | | HF4 | | Name: | 4-amino-1-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}pyrimidin-2(1H)-one | | Formula: | C9 H16 N3 O14 P3 | | SMILES: | C=1N(C(=O)N=C(N)C=1)C2C(C(C(COP(OP(OP(=O)(O)O)(O)=O)(O)=O)O2)O)O | | InChi: | InChI=1S/C9H16N3O14P3/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H2,10,11,15)(H2,16,17,18)/t4-,6-,7+,8-/m1/s1 | | Synonyms: | Cytarabine-TRIPHOSPHATE | | Definition date: | 2018-06-27 | | Last modified: | 2021-03-01 | | Release date: | 2018-10-10 | | Identifier: | 4-amino-1-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}pyrimidin-2(1H)-one |
|
 | | HFG | | Name: | 7-bromo-6-chloro-3-{3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3H)-one | | Formula: | C16 H17 Br Cl N3 O3 | | SMILES: | Brc3c(Cl)cc1c(N=CN(C1=O)CC(=O)CC2NCCCC2O)c3 | | InChi: | InChI=1S/C16H17BrClN3O3/c17-11-6-13-10(5-12(11)18)16(24)21(8-20-13)7-9(22)4-14-15(23)2-1-3-19-14/h5-6,8,14-15,19,23H,1-4,7H2/t14-,15+/m1/s1 | | Synonyms: | Halofuginone | | Definition date: | 2012-11-09 | | Last modified: | 2021-03-01 | | Release date: | 2012-12-28 | | Identifier: | 7-bromo-6-chloro-3-{3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3H)-one |
|
 | | HGG | | Name: | (3R,5S,9R,21S)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9,21-tetrahydroxy-8,8-dimethyl-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphatricosan-23-oic acid 3,5-dioxide | | Formula: | C26 H42 N7 O20 P3 S | | SMILES: | O=C(O)CC(O)CC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3OP(=O)(O)O | | InChi: | InChI=1S/C26H42N7O20P3S/c1-26(2,21(40)24(41)29-4-3-15(35)28-5-6-57-17(38)8-13(34)7-16(36)37)10-50-56(47,48)53-55(45,46)49-9-14-20(52-54(42,43)44)19(39)25(51-14)33-12-32-18-22(27)30-11-31-23(18)33/h11-14,19-21,25,34,39-40H,3-10H2,1-2H3,(H,28,35)(H,29,41)(H,36,37)(H,45,46)(H,47,48)(H2,27,30,31)(H2,42,43,44)/t13-,14+,19+,20+,21-,25+/m0/s1 | | Synonyms: | 3-Hydroxyl Glutaryl CoA | | Definition date: | 2010-04-29 | | Last modified: | 2021-03-01 | | Identifier: | (3R,5S,9R,21S)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9,21-tetrahydroxy-8,8-dimethyl-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphatricosan-23-oic acid 3,5-dioxide (non-preferred name) |
|
 | | HGI | | Name: | MERCURY (II) IODIDE | | Formula: | Hg I2 | | SMILES: | I[Hg]I | | InChi: | InChI=1S/Hg.2HI/h | | Synonyms: | MERCURY DIIODIDE | | Definition date: | 2001-06-20 | | Last modified: | 2021-03-01 | | Identifier: | mercury diiodide |
|
 | | HH0 | | Name: | methyl N-[(2S)-2-({(S)-hydroxy[(1R)-3-methyl-1-{[N-(3-methylbutanoyl)-L-valyl-L-valyl]amino}butyl]phosphoryl}oxy)-3-phenylpropanoyl]-L-alanyl-L-alaninate | | Formula: | C36 H60 N5 O10 P | | SMILES: | O=C(OC)C(NC(=O)C(NC(=O)C(OP(=O)(O)C(NC(=O)C(NC(=O)C(NC(=O)CC(C)C)C(C)C)C(C)C)CC(C)C)Cc1ccccc1)C)C | | InChi: | InChI=1S/C36H60N5O10P/c1-20(2)17-28(42)39-30(22(5)6)35(46)41-31(23(7)8)34(45)40-29(18-21(3)4)52(48,49)51-27(19-26-15-13-12-14-16-26)33(44)37-24(9)32(43)38-25(10)36(47)50-11/h12-16,20-25,27,29-31H,17-19H2,1-11H3,(H,37,44)(H,38,43)(H,39,42)(H,40,45)(H,41,46)(H,48,49)/t24-,25-,27-,29+,30-,31-/m0/s1 | | Synonyms: | IVA-VAL-VAL-LEU(P)-(O)PHE-ALA-ALA-OME | | Definition date: | 2010-11-02 | | Last modified: | 2021-03-01 | | Identifier: | methyl N-[(2S)-2-({(S)-hydroxy[(1R)-3-methyl-1-{[N-(3-methylbutanoyl)-L-valyl-L-valyl]amino}butyl]phosphoryl}oxy)-3-phenylpropanoyl]-L-alanyl-L-alaninate |
|
 | | HH2 | | Name: | 6-HYDROXYMETHYLPTERIN-DIPHOSPHATE | | Formula: | C7 H9 N5 O8 P2 | | SMILES: | O=P(O)(O)OP(=O)(O)OCc1nc2C(=O)NC(=Nc2nc1)N | | InChi: | InChI=1S/C7H9N5O8P2/c8-7-11-5-4(6(13)12-7)10-3(1-9-5)2-19-22(17,18)20-21(14,15)16/h1H,2H2,(H,17,18)(H2,14,15,16)(H3,8,9,11,12,13) | | Synonyms: | [PTERIN-6-YL METHANYL]-PHOSPHONOPHOSPHATE | | Definition date: | 2000-12-21 | | Last modified: | 2021-03-01 | | Identifier: | (2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl trihydrogen diphosphate |
|
 | | HID | | Name: | (5-hydroxy-1H-indol-3-yl)acetic acid | | Formula: | C10 H9 N O3 | | SMILES: | OC(=O)Cc1c[nH]c2ccc(O)cc12 | | InChi: | InChI=1S/C10H9NO3/c12-7-1-2-9-8(4-7)6(5-11-9)3-10(13)14/h1-2,4-5,11-12H,3H2,(H,13,14) | | Synonyms: | 5-hydroxy-indole acetate | | Definition date: | 2010-02-08 | | Last modified: | 2021-03-01 | | Identifier: | 2-(5-hydroxy-1H-indol-3-yl)ethanoic acid |
|
